RS62249B1 - Mimetici odbrambenog proteina domaćina (hdp) za profilaksu i/ili tretman inflamatornih bolesti gastrointestinalnog trakta - Google Patents

Mimetici odbrambenog proteina domaćina (hdp) za profilaksu i/ili tretman inflamatornih bolesti gastrointestinalnog trakta

Info

Publication number
RS62249B1
RS62249B1 RS20210876A RSP20210876A RS62249B1 RS 62249 B1 RS62249 B1 RS 62249B1 RS 20210876 A RS20210876 A RS 20210876A RS P20210876 A RSP20210876 A RS P20210876A RS 62249 B1 RS62249 B1 RS 62249B1
Authority
RS
Serbia
Prior art keywords
hdp
mimetics
prophylaxis
treatment
gastrointestinal tract
Prior art date
Application number
RS20210876A
Other languages
English (en)
Inventor
Krishna Menon
Original Assignee
Innovation Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Pharmaceuticals Inc filed Critical Innovation Pharmaceuticals Inc
Publication of RS62249B1 publication Critical patent/RS62249B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20210876A 2015-02-20 2016-02-09 Mimetici odbrambenog proteina domaćina (hdp) za profilaksu i/ili tretman inflamatornih bolesti gastrointestinalnog trakta RS62249B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562118950P 2015-02-20 2015-02-20
PCT/US2016/017061 WO2016133733A1 (en) 2015-02-20 2016-02-09 Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract
EP16752799.3A EP3258927B8 (en) 2015-02-20 2016-02-09 Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract

Publications (1)

Publication Number Publication Date
RS62249B1 true RS62249B1 (sr) 2021-09-30

Family

ID=56689106

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20210876A RS62249B1 (sr) 2015-02-20 2016-02-09 Mimetici odbrambenog proteina domaćina (hdp) za profilaksu i/ili tretman inflamatornih bolesti gastrointestinalnog trakta

Country Status (15)

Country Link
US (3) US20160243117A1 (sr)
EP (1) EP3258927B8 (sr)
JP (1) JP6047203B2 (sr)
CN (1) CN107613967A (sr)
AU (1) AU2016220373B2 (sr)
DK (1) DK3258927T3 (sr)
ES (1) ES2881429T3 (sr)
HR (1) HRP20211107T1 (sr)
HU (1) HUE055090T2 (sr)
LT (1) LT3258927T (sr)
PL (1) PL3258927T3 (sr)
PT (1) PT3258927T (sr)
RS (1) RS62249B1 (sr)
SI (1) SI3258927T1 (sr)
WO (1) WO2016133733A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
DK2709619T3 (en) 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
KR20180080189A (ko) 2015-09-01 2018-07-11 퍼스트 웨이브 바이오, 인코포레이티드 이상 염증 반응과 연관된 질환을 치료하기 위한 방법 및 조성물
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629317B2 (en) * 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
JP5209302B2 (ja) * 2004-06-15 2013-06-12 ポリメディックス、インク. ポリカチオン化合物とその使用
US8017576B2 (en) * 2005-05-10 2011-09-13 The University Of Chicago Methods and compositions to treat mucositis
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US8278309B2 (en) * 2008-10-27 2012-10-02 Polymedix, Inc. Synthetic mimetics of host defense and uses thereof
DK2709619T3 (en) * 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS

Also Published As

Publication number Publication date
US20160243117A1 (en) 2016-08-25
DK3258927T3 (da) 2021-07-19
HUE055090T2 (hu) 2021-10-28
SI3258927T1 (sl) 2022-03-31
EP3258927A1 (en) 2017-12-27
JP6047203B2 (ja) 2016-12-21
EP3258927B1 (en) 2021-06-09
ES2881429T3 (es) 2021-11-29
AU2016220373A1 (en) 2017-10-12
PL3258927T3 (pl) 2021-11-08
CN107613967A (zh) 2018-01-19
US11666571B2 (en) 2023-06-06
AU2016220373B2 (en) 2020-10-22
US20230310435A1 (en) 2023-10-05
EP3258927B8 (en) 2021-09-15
LT3258927T (lt) 2021-09-27
JP2016153386A (ja) 2016-08-25
PT3258927T (pt) 2021-07-22
WO2016133733A1 (en) 2016-08-25
HRP20211107T1 (hr) 2021-10-15
US20200368232A1 (en) 2020-11-26
EP3258927A4 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
ZA201807098B (en) Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract
LT3258927T (lt) Šeimininko apsauginių baltymų (hdp) mimetikai, skirti uždegiminių virškinamojo trakto ligų profilaktikai ir (arba) gydymui
IL256630A (en) Combined separator and coagulator
PT3297628T (pt) Azasetron para uso no tratamento de perda auditiva
GB2554354B (en) Systems for adaptive treatment of disorders in the gastrointestinal tract
EP3348273B8 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
ZA201903893B (en) Treatment of respiratory tract diseases and infections with glutathione compositions
EP3428178A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
FI3197556T3 (fi) Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi
EP3509614A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LAFORA DISEASE
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
GB201515244D0 (en) Treatment of inflammatory disease or condition
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
EP3428179A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
WO2015113041A3 (en) Compositions and methods for treating autoimmune and inflammatory diseases
AU2018903823A0 (en) Compositions and methods of treatment of conditions of the gastrointestinal tract
EP3854402C0 (en) TREATMENT OR PREVENTION OF GRAFT-VERSE-HOST DISEASE
GB201809835D0 (en) Treatment of gastrointestinal disease
PL3616687T3 (pl) Preparat do leczenia i/lub profilaktyki zapalnych chorób zakaźnych
HK1250343A1 (zh) 用於治療聽力損失的司瓊類鈣調神經磷酸酶抑制劑
AU2015900887A0 (en) Treatment and detection of inflammatory disease
EP3270963A4 (en) Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
AU2015902358A0 (en) Treatment of inflammatory disease